Get the Stockscreener App
3.1994
2.92%
-0.1006
Neuronetics Inc stock is traded at $3.1994, with a volume of 1.36M.
It is down -2.92% in the last 24 hours and up +97.75% over the past month.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
See More
Previous Close:
$3.30
Open:
$3.272
24h Volume:
1.36M
Relative Volume:
0.55
Market Cap:
$223.03M
Revenue:
$151.64M
Net Income/Loss:
$-37.23M
P/E Ratio:
-5.8554
EPS:
-0.5464
Net Cash Flow:
$-13.58M
1W Performance:
+47.63%
1M Performance:
+97.75%
6M Performance:
+124.02%
1Y Performance:
-4.09%
1-Day Range:
$3.06
$3.40
1-Week Range:
$2.71
$3.44
52-Week Range:
$0.80
$3.80
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.205 | 229.64M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
110.19 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.71 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.83 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.60 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.88 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - stocktitan.net
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics, Inc. (STIM) stock price, news, quote and history - Yahoo Finance Australia
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - benzinga.com
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase - Yahoo Finance
Why is Neuronetics stock surging today? By Investing.com - Investing.com Nigeria
Neuronetics (NASDAQ:STIM) Announces Earnings Results - MarketBeat
Why is Neuronetics stock surging today? - Investing.com
Neuronetics Q2 2026 slides: mental health platform beats on margins - Investing.com
Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy - Bitget
Neuronetics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Neuronetics STIM Draws Buy Rating As Vertical Psychiatry Platform Scales Up - StocksToTrade
Form 8K Neuronetics Inc For: 11 August By Investing.com - Investing.com South Africa
Is Neuronetics Inc (STIM) Positioned for Growth After Q2 Earnings Miss? GF Score: 60/100 - GuruFocus
Neuronetics stock soars 15% on second quarter earnings beat By Investing.com - Investing.com South Africa
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
STIM Looks 11.3% Overvalued on GF Value™ - GuruFocus
Q2 2026 Neuronetics Inc Earnings Call Transcript - GuruFocus
Neuronetics stock soars 15% on second quarter earnings beat - Investing.com
NEURONETICS ($STIM) Releases Q2 2026 Earnings - Quiver Quantitative
Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength - TradingView
Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA - Quiver Quantitative
Neuronetics: Q2 Earnings Snapshot - ktvb.com
Press Release: Neuronetics Reports Second Quarter 2026 Financial and Operating Results - Moomoo
Neuronetics Inc. (STIM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Neuronetics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Earnings Preview: Neuronetics to Report Financial Results Pre-market on August 11 - Moomoo
Jorey Chernett gains board input rights at Neuronetics (STIM) - Stock Titan
Neuronetics reaches accord with activist investor after sale pressure - The Business Journals
Neuronetics and Jorey Chernett Announce Shared Vision - The Manila Times
Weekly Recap: Q2 2026 results release and Rockville center opening - TradingView
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):